Akt inhibition improves long‐term tumour control following radiotherapy by altering the microenvironment

Radiotherapy is an important anti‐cancer treatment, but tumour recurrence remains a significant clinical problem. In an effort to improve outcomes further, targeted anti‐cancer drugs are being tested in combination with radiotherapy. Here, we have studied the effects of Akt inhibition with AZD5363....

Descripción completa

Detalles Bibliográficos
Autores principales: Searle, Emma J, Telfer, Brian A, Mukherjee, Debayan, Forster, Duncan M, Davies, Barry R, Williams, Kaye J, Stratford, Ian J, Illidge, Tim M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709765/
https://www.ncbi.nlm.nih.gov/pubmed/29084756
http://dx.doi.org/10.15252/emmm.201707767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709765/
https://www.ncbi.nlm.nih.gov/pubmed/29084756
http://dx.doi.org/10.15252/emmm.201707767

Ejemplares similares